GlassScriptPhysician profile
Heidi M Taft
NPI 1679886659
$7,200.53
in general payments reported to CMS, 2019-2025
49 companies · $766 in 2025
The $766 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,516 · 2022: $1,418 · 2023: $1,872 · 2024: $1,628 · 2025: $766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,266.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,353.29 | 2021-2025 | |
| Novo Nordisk INC | $1,056.41 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $492.16 | 2021-2025 | Otezla, Repatha, Evenity |
| Glaxosmithkline, LLC. | $450.10 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $412.43 | 2021-2025 | Emgality, Mounjaro, Reyvow |
| Abbott Laboratories | $405.94 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Pfizer INC. | $285.72 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.05 | 2021-2025 | Tradjenta, Jardiance |
| Esperion Therapeutics, INC. | $211.83 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $211.31 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $195.95 | 2021-2024 | |
| Axsome Therapeutics, INC. | $169.39 | 2024 | Auvelity |
| Eisai INC. | $132.20 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.70 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $99.85 | 2022-2025 | Rexulti |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Taft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.